drugset / Trial / NCT00866580
A Study for Evaluation of GSK Biologicals' Pandemic Influenza Vaccine
RandomizedParallel-groupTriple-blindPrevention
Summary
This observer-blind study is designed to evaluate the immune response and safety of pandemic influenza vaccine in the elderly population.
Timeline
- Start
- 2010-05
- Primary completion
- 2011-07
- Completion
- 2011-07
Outcome
Outcome not reported
Stopped: “Study was cancelled before enrolment for reasons not related to vaccine safety or efficacy.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FluarixTM | Vaccine | — | Intramuscular |
| Subject | GSK1562902A | Vaccine | — | Intramuscular |